India's Financial Express reports ("Domestic pharma cos fare well in patent litigation tests") on the pharma patent litigation success rates of India's leading pharmaceutical companies in US litigation over the past decade. Lupin Pharma has a success rate of 75%, while Sun Pharma (67%), Ranbaxy (63%) and Dr Reddy’s (61%) are not far behind. The article also gives a neat thumbnail sketch of the pharma patent litigation environment.
Friday, 22 January 2010
Indian pharma sector "fares well" in US disputes
India's Financial Express reports ("Domestic pharma cos fare well in patent litigation tests") on the pharma patent litigation success rates of India's leading pharmaceutical companies in US litigation over the past decade. Lupin Pharma has a success rate of 75%, while Sun Pharma (67%), Ranbaxy (63%) and Dr Reddy’s (61%) are not far behind. The article also gives a neat thumbnail sketch of the pharma patent litigation environment.
Subscribe to:
Post Comments (Atom)
2 comments:
Is anyone else inappropriately amused by Lupin's logo? Do they, perhaps, sell a generic equivalent of Viagra?
bawmothLupin's logo was concieved (pun not intended) decades before Viagra was even a twinkle in its inventor's eyes !!!!!!
Post a Comment